Aortic Valve Market Size: Information by Valve Type (Mechanical and Biological), Suture Type (Suture and Sutureless), Surgery Type (Minimally Invasive Surgery (Transfemoral, Transaortic Implantation, Transapical, and Trans-subclavian) and Open surgery), End-User (Hospitals, Ambulatory Surgery Centers) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2025Market HighlightsAccording to MRFR analysis, Aortic Valve Market Size is expected to register a CAGR of 11.1% during the forecast period of 2019 to 2025 and held a value of USD 6,454.91 Million in 2018.An aortic valve is surgically implanted in the heart to replace a valve that has damaged due to heart valve diseases such as stenosis, regurgitation, and atresia.
The replacement of damaged valves with prosthetic heart valves reduces the morbidity and mortality associated with aortic valve disorders.The growth of the global Aortic Valve Market Size is boosted by various factors such as the rising geriatric population, surge in prevalence of cardiac disorders, in conjunction with the introduction of innovative products in the market.
According to the Heart Valve Voice, approximately 1.5 million people over the age of 65 years are currently affected by heart valve disease in the UK, and the number is expected to increase up to 19 million by 2050.
The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada.
The Western European market has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The Aortic Valve Market Size in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The source of the artificial valve used, includes mechanical valves, which are created from man-made materials; and tissue valves, which are created from pig, cow, or human donors.
Minimally invasive surgeries include aortic valve balloon valvuloplasty, transcatheter aortic valve implantation (TAVI), and sutureless aortic valve replacement, among others.
Hospitals, ambulatory surgical centers and cardiac catheterization laboratories form the major end-users for the market.
In addition, changing lifestyles, leading to obesity; increasing cardiovascular diseases, growing health awareness, and increasing global geriatric population also contribute to the growth of the aortic valve replacement market.
The risks associated with the replacement procedures, high costs, and growing regulations related to product approvals, would negatively impact the aortic valve replacement market.TAVI, and aortic valve replacement employing a tissue valve, are the common techniques used for aortic valve replacement.
In terms of geography, North America had the largest share in the aortic valve replacement market followed by Europe due to the increasing obesity and growing geriatric population in the region.
Aortic Valve Market: Information by Valve Type (Mechanical and Biological), Suture Type (Suture and Sutureless), Surgery Type (Minimally Invasive Surgery (Transfemoral, Transaortic Implantation, Transapical, and Trans-subclavian) and Open surgery), End User (Hospitals, Ambulatory Surgery Centers) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) – Forecast till 2025Market HighlightsAccording to MRFR analysis, Aortic Valve Market is expected to register a CAGR of 11.1% during the forecast period of 2019 to 2025 and held a value of USD 6,454.91 Million in 2018.An aortic valve is surgically implanted in the heart to replace a valve that has damaged due to heart valve diseases such as stenosis, regurgitation, and atresia.
The replacement of damaged valves with prosthetic heart valves reduces the morbidity and mortality associated with aortic valve disorders.The growth of the global aortic valve market is boosted by various factors such as the rising geriatric population, surge in prevalence of cardiac disorders, in conjunction with the introduction of innovative products in the market.
According to the Heart Valve Voice, approximately 1.5 million people over the age of 65 years are currently affected by heart valve disease in the UK, and the number is expected to increase up to 19 million by 2050.
The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada.
The Western European market has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The aortic valve market in Asia Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
Aortic Valve Market Size: Information by Valve Type (Mechanical and Biological), Suture Type (Suture and Sutureless), Surgery Type (Minimally Invasive Surgery (Transfemoral, Transaortic Implantation, Transapical, and Trans-subclavian) and Open surgery), End-User (Hospitals, Ambulatory Surgery Centers) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) - Forecast till 2025Market HighlightsAccording to MRFR analysis, Aortic Valve Market Size is expected to register a CAGR of 11.1% during the forecast period of 2019 to 2025 and held a value of USD 6,454.91 Million in 2018.An aortic valve is surgically implanted in the heart to replace a valve that has damaged due to heart valve diseases such as stenosis, regurgitation, and atresia.
The replacement of damaged valves with prosthetic heart valves reduces the morbidity and mortality associated with aortic valve disorders.The growth of the global Aortic Valve Market Size is boosted by various factors such as the rising geriatric population, surge in prevalence of cardiac disorders, in conjunction with the introduction of innovative products in the market.
According to the Heart Valve Voice, approximately 1.5 million people over the age of 65 years are currently affected by heart valve disease in the UK, and the number is expected to increase up to 19 million by 2050.
The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada.
The Western European market has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The Aortic Valve Market Size in Asia-Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.
The source of the artificial valve used, includes mechanical valves, which are created from man-made materials; and tissue valves, which are created from pig, cow, or human donors.
Minimally invasive surgeries include aortic valve balloon valvuloplasty, transcatheter aortic valve implantation (TAVI), and sutureless aortic valve replacement, among others.
Hospitals, ambulatory surgical centers and cardiac catheterization laboratories form the major end-users for the market.
In addition, changing lifestyles, leading to obesity; increasing cardiovascular diseases, growing health awareness, and increasing global geriatric population also contribute to the growth of the aortic valve replacement market.
The risks associated with the replacement procedures, high costs, and growing regulations related to product approvals, would negatively impact the aortic valve replacement market.TAVI, and aortic valve replacement employing a tissue valve, are the common techniques used for aortic valve replacement.
In terms of geography, North America had the largest share in the aortic valve replacement market followed by Europe due to the increasing obesity and growing geriatric population in the region.
Aortic Valve Market: Information by Valve Type (Mechanical and Biological), Suture Type (Suture and Sutureless), Surgery Type (Minimally Invasive Surgery (Transfemoral, Transaortic Implantation, Transapical, and Trans-subclavian) and Open surgery), End User (Hospitals, Ambulatory Surgery Centers) and Region (Americas, Europe, Asia-Pacific, and the Middle East & Africa) – Forecast till 2025Market HighlightsAccording to MRFR analysis, Aortic Valve Market is expected to register a CAGR of 11.1% during the forecast period of 2019 to 2025 and held a value of USD 6,454.91 Million in 2018.An aortic valve is surgically implanted in the heart to replace a valve that has damaged due to heart valve diseases such as stenosis, regurgitation, and atresia.
The replacement of damaged valves with prosthetic heart valves reduces the morbidity and mortality associated with aortic valve disorders.The growth of the global aortic valve market is boosted by various factors such as the rising geriatric population, surge in prevalence of cardiac disorders, in conjunction with the introduction of innovative products in the market.
According to the Heart Valve Voice, approximately 1.5 million people over the age of 65 years are currently affected by heart valve disease in the UK, and the number is expected to increase up to 19 million by 2050.
The Americas held the maximum share in the base year 2018, owing to the presence of established key players in countries such as the US and Canada.
The Western European market has been classified as Germany, France, the UK, Italy, Spain, and the rest of Western Europe.
The aortic valve market in Asia Pacific has been segmented into Japan, China, India, South Korea, Australia, and the rest of Asia-Pacific.